Neuronetics Q2 2024 GAAP EPS $(0.33) Misses $(0.27) Estimate, Sales $16.450M Miss $18.648M Estimate
Portfolio Pulse from Benzinga Newsdesk
Neuronetics reported its Q2 2024 financial results, with a GAAP EPS of $(0.33), missing the $(0.27) estimate. Sales were $16.450M, falling short of the $18.648M estimate.
August 12, 2024 | 11:13 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neuronetics (STIM) reported disappointing Q2 2024 financial results, with both GAAP EPS and sales missing estimates. GAAP EPS was $(0.33) versus the $(0.27) estimate, and sales were $16.450M compared to the $18.648M estimate.
Neuronetics' Q2 2024 financial results were below expectations, with both GAAP EPS and sales missing estimates. This is likely to negatively impact the stock price in the short term as investors react to the disappointing performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100